Announcements Trials
Browse Landscape

Phase

Phase NA 39Phase 2 6Phase 4 5Phase 1/2 3Phase EARLY_PHASE1 2Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 5NIH 4NETWORK 2OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 552Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 137Rectal Neoplasms 135Multiple Myeloma 133Nasopharyngeal Carcinoma 112Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Acquired Immunodeficiency Syndrome × Clear all
NCT02358226 2020-02-17

HIV & Drug Abuse Prevention for South African Men

University of California, Los Angeles

Phase 3 Completed
1,211 enrolled
Endocrine

Acquired Immunodeficiency Syndrome, Alcoholism, Multiple Endocrine Neoplasia Type 1, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡